共 50 条
Multiple Acyl-CoA Dehydrogenase Deficiency: Phenotypic and Genetic Features of a Malaysian Cohort
被引:0
|作者:
Schee, Jie Ping
[1
]
Tan, Joo San
[2
]
Tan, Cheng Yin
[1
]
Shahrizaila, Nortina
[1
]
Wong, Kum Thong
[2
,3
]
Goh, Khean Jin
[1
]
机构:
[1] Univ Malaya, Fac Med, Dept Med, Div Neurol, Kuala Lumpur, Malaysia
[2] Univ Malaya, Fac Med, Dept Pathol, Kuala Lumpur, Malaysia
[3] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Subang Jaya, Selangor, Malaysia
来源:
JOURNAL OF CLINICAL NEUROLOGY
|
2024年
/
20卷
/
04期
关键词:
multiple acyl-CoA dehydrogenase deficiency;
electron-transfer flavoprotein dehydrogenase;
lipid storage myopathy;
LATE-ONSET;
CLINICAL-FEATURES;
ETFDH MUTATIONS;
RIBOFLAVIN;
PATIENT;
FLAVOPROTEIN;
VARIANTS;
D O I:
10.3988/jcn.2023.0265
中图分类号:
R74 [神经病学与精神病学];
学科分类号:
摘要:
Background and Purpose Multiple acyl-CoA dehydrogenase deficiency (MADD) is an inherited disorder of fatty acid oxidation that causes lipid storage myopathy (LSM). This is the first report on MADD that describes the phenotypic and genetic features of a Malaysian cohort. Methods Among the >2,500 patients in a local muscle biopsy database, patients with LSM were identified and their genomic DNA were extracted from muscle samples and peripheral blood. All 13 exons of the electron -transfer flavoprotein dehydrogenase gene ( ETFDH ) were subsequently sequenced. Fifty controls were included to determine the prevalence of identified mutations in the normal population. Results Fourteen (82%) of the 17 LSM patients had MADD with ETFDH mutations. Twelve (86%) were Chinese and two were Malay sisters. Other unrelated patients reported that they had no relevant family history. Nine (64%) were females. The median age at onset was 18.5 years (interquartile range=16-37 years). All 14 demonstrated proximal limb weakness, elevated serum creatine kinase levels, and myopathic changes in electromyography. Three patients experienced a metabolic crisis at their presentation. Sanger sequencing of ETFDH revealed nine different variants/mutations, one of which was novel: c.998A>G (p.Y333C) in exon 9. Notably, 12 (86%) patients, including the 2 Malay sisters, carried a common c.250G>A (p.A84T) variant, consistent with the hotspot mutation reported in southern China. All of the patients responded well to riboflavin therapy. Conclusions Most of our Malaysian cohort with LSM had late -onset, riboflavin -responsive MADD with ETFDH mutations, and they demonstrated phenotypic and genetic features similar to those of cases reported in southern China. Furthermore, we report a novel ETFDH mutation and possibly the first ever MADD patients of Malay descent.
引用
收藏
页码:422 / 430
页数:9
相关论文